// App-Quantinova.ai

: A PROSPECTIVE STUDY OF TAPERING CONVENTIONAL DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (C- DMARDS) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN STABLE REMISSION

Researchers

Presenter

  • SHAH ROMI

Principal Investigators

  • Canchi Balakrishnan

Medical Centers

  • D Hinduja Hospital and Medical Research Center, Mumbai, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

  • sulphasalazine

  • Methotrexate

  • HWA-486

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved